(Post-pandemic Era)-Global Blood Metabolites POC Analyzer Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Report Code : XYZ2438597
- Published On: Apr, 2021
- Category : Medical Devices
- Pages : 118
-
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Research published a report for global Blood Metabolites POC Analyzer market in this environment.
In terms of revenue, this research report indicated that the global Blood Metabolites POC Analyzer market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Blood Metabolites POC Analyzer industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Dr. Muller Geratebau aims at producing XX K Units Blood Metabolites POC Analyzer in 2020, with XX % production to take place in global market, Biochemical Systems International accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Blood Metabolites POC Analyzer Market Include by
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Blood Metabolites POC Analyzer Market
Dr. Muller Geratebau
Biochemical Systems International
TaiDoc Technology
DiaSys Diagnostic Systems
Siemens
Medica
Roche
Erba
Nova Stat
Bayer
Radiometer Medical
Samsung Medison
Edan Instruments
OPTI Medical Systems Inc.
Alere Medical
Convergent Technologies
Dalko Diagnostics
Afford Medical
Accurex Biomedical Pvt. Ltd..
Major Type of Blood Metabolites POC Analyzer Covered in Research report:
Benchtop
Portable
Application Segments Covered in Research Market
Hospital
Point-of-care
Laboratory
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
-
With tables and figures helping analyze worldwide (Post pandemic Era) Global Blood Metabolites POC Analyzer market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Global Blood Metabolites POC Analyzer Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope1.1 Product Details and Introduction
1.1.1 Benchtop -Product Introduction and Major Manufacturers
1.1.2 Portable -Product Introduction and Major Manufacturers1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Blood Metabolites POC Analyzer Market Assessment, by Segmentation2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis3.1 China Blood Metabolites POC Analyzer Market
3.1.1 Top Companies leading Blood Metabolites POC Analyzer Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Blood Metabolites POC Analyzer Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)3.2 EU Blood Metabolites POC Analyzer Market
3.2.1 Top Companies leading Blood Metabolites POC Analyzer Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Blood Metabolites POC Analyzer Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)3.3 USA Blood Metabolites POC Analyzer Market
3.3.1 Top Companies leading Blood Metabolites POC Analyzer Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Blood Metabolites POC Analyzer Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)3.4 Japan Blood Metabolites POC Analyzer Market
3.4.1 Top Companies leading Blood Metabolites POC Analyzer Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Blood Metabolites POC Analyzer Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)3.5 India Blood Metabolites POC Analyzer Market
3.5.1 Top Companies leading Blood Metabolites POC Analyzer Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Blood Metabolites POC Analyzer Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)3.6 Southeast Asia Blood Metabolites POC Analyzer Market
3.6.1 Top Companies leading Blood Metabolites POC Analyzer Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Blood Metabolites POC Analyzer Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Blood Metabolites POC Analyzer Market
3.7.1 Top Companies leading Blood Metabolites POC Analyzer Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Blood Metabolites POC Analyzer Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)4.1 Blood Metabolites POC Analyzer Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream4.2 COVID-19 Impact on Blood Metabolites POC Analyzer Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)5.1 Global Blood Metabolites POC Analyzer Sales and Growth Rate (2021-2027)
5.2 Global Blood Metabolites POC Analyzer Sales Value and Growth Rate (2021-2027)
6 Blood Metabolites POC Analyzer Competitive Analysis6.1 Dr. Muller Geratebau
6.1.1 Dr. Muller Geratebau Company Profiles
6.1.2 Dr. Muller Geratebau Product Introduction
6.1.3 Dr. Muller Geratebau Blood Metabolites POC Analyzer Production, Revenue (2016-2021)
6.1.4 SWOT Analysis6.2 Biochemical Systems International
6.2.1 Biochemical Systems International Company Profiles
6.2.2 Biochemical Systems International Product Introduction
6.2.3 Biochemical Systems International Blood Metabolites POC Analyzer Production, Revenue (2016-2021)
6.2.4 SWOT Analysis6.3 TaiDoc Technology
6.3.1 TaiDoc Technology Company Profiles
6.3.2 TaiDoc Technology Product Introduction
6.3.3 TaiDoc Technology Blood Metabolites POC Analyzer Production, Revenue (2016-2021)
6.3.4 SWOT Analysis6.4 DiaSys Diagnostic Systems
6.4.1 DiaSys Diagnostic Systems Company Profiles
6.4.2 DiaSys Diagnostic Systems Product Introduction
6.4.3 DiaSys Diagnostic Systems Blood Metabolites POC Analyzer Production, Revenue (2016-2021)
6.4.4 SWOT Analysis6.5 Siemens
6.5.1 Siemens Company Profiles
6.5.2 Siemens Product Introduction
6.5.3 Siemens Blood Metabolites POC Analyzer Production, Revenue (2016-2021)
6.5.4 SWOT Analysis6.6 Medica
6.6.1 Medica Company Profiles
6.6.2 Medica Product Introduction
6.6.3 Medica Blood Metabolites POC Analyzer Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Roche
6.7.1 Roche Company Profiles
6.7.2 Roche Product Introduction
6.7.3 Roche Blood Metabolites POC Analyzer Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Erba
6.8.1 Erba Company Profiles
6.8.2 Erba Product Introduction
6.8.3 Erba Blood Metabolites POC Analyzer Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Nova Stat
6.9.1 Nova Stat Company Profiles
6.9.2 Nova Stat Product Introduction
6.9.3 Nova Stat Blood Metabolites POC Analyzer Production, Revenue (2016-2021)
6.9.4 SWOT Analysis6.10 Bayer
6.10.1 Bayer Company Profiles
6.10.2 Bayer Product Introduction
6.10.3 Bayer Blood Metabolites POC Analyzer Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Radiometer Medical
6.12 Samsung Medison
6.13 Edan Instruments
6.14 OPTI Medical Systems Inc.
6.15 Alere Medical
6.16 Convergent Technologies
6.17 Dalko Diagnostics
6.18 Afford Medical
6.19 Accurex Biomedical Pvt. Ltd..
7 Conclusion
-
The (Post pandemic Era) Global Blood Metabolites POC Analyzer Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
New players are entering the (Post pandemic Era) Global Blood Metabolites POC Analyzer Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
Depending upon the type of applications, the (Post pandemic Era) Global Blood Metabolites POC Analyzer Market has been segmented into
The (Post pandemic Era) Global Blood Metabolites POC Analyzer Market is expected to grow at a moderate CAGR during the forecast period of 2024 to 2029.
In addition to the (Post pandemic Era) Global Blood Metabolites POC Analyzer Market share analysis by competitors, the report also includes chapters on the HHI Index, CR4, and CR8 to characterize the concentration rate and competitive character of the (Post pandemic Era) Global Blood Metabolites POC Analyzer Market.
The (Post pandemic Era) Global Blood Metabolites POC Analyzer Market is expected to reach a considerable market valuation.
